Dose optimisation of 18F-flurodeoxyglucose for whole body PET oncology examination in CDNI of UPM

QR Code

Dose optimisation of 18F-flurodeoxyglucose for whole body PET oncology examination in CDNI of UPM

A shift to administration of optimal dose of18F-FDG between 4 and 5 MBq/kg from the current practice of higher doses potentially yields a reasonable-to-excellent PET image. For this purpose, whole-body MIP images of 32 patients (23 men, 9 women, age 51.9 ± 13.7 years), administered with 18F-FDG (act...

Full description

Bibliographic Details
Main Authors:	Hassan, Hishar, Mustafa, Salasiah, Ahmad Saad, Fathinul Fikri, Nordin, Abdul Jalil
Other Authors:	Osman, Mohd Nizam
Format:	Article
Language:	English
Published:	Universiti Putra Malaysia Press 2015
Online Access:	http://psasir.upm.edu.my/id/eprint/32731/ http://psasir.upm.edu.my/id/eprint/32731/1/03%20JST-0524-2014%20Short%20Comm%20Rev.pdf

Similar Items

18F FDG PET-CT in oncology & interesting images
by: Ahmad Saad, Fathinul Fikri
Published: (2015)

Applications of 18(F) FDG PET/CT in oncology
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2015)

Impact of total activity variation in 18F-FDG injected with the overall PET image quality in oncology patients
by: Hassan, Muhammad Hishar, et al.
Published: (2012)

Estimation of patient radiation dose from whole body 18F-FDG PET/CT examination in cancer imaging: a preliminary study
by: Mahmud, Mohd Hafizi, et al.
Published: (2014)

Improvement in lesion detection with whole-body oncologic time-of-flight PET
by: El Fakhri, G., et al.
Published: (2011)

The value of 18F-fluorodeoxyglucose PET (18F-FDG PET) and MRI spectroscopy in underpinning suspicious breast cancer
by: Shaharuddin, Shazreen, et al.
Published: (2018)

Potential of 3'-fluoro-3' deoxythymidine as a cellular proliferation marker in PET oncology examination
by: Hassan, Hishar, et al.
Published: (2016)

Potential of 3’-fluoro-3’ deoxythymidine as a cellular proliferation marker in PET oncology examination
by: Hassan, Hishar, et al.
Published: (2016)

18F-FDG PET/CT as a potential valuable adjunct to MRI in characterising the Brodies abscess
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2010)

18F-FDG PET/CT as a potential valuable adjunct to MRI in characterising the Brodie's abscess
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2010)

Role Of Positron Emission Tomography With Computed Tomography Using F-18 Flurodeoxyglucose In Detection Of Carcinoma Of Unknown Primary In Malaysia
by: Samsudin, Nursazlinda
Published: (2016)

18F-FDG-PET CT features of colo-colic intussusceptions in patient with colonic carcinoma
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2016)

The value of 18F-fluorodeoxyglucose-positron emission tomography/ computed tomography (18F- FDG PET/CT) in the staging and impact on the management of patients with nasopharyngeal carcinoma
by: Subha, Sethu Thakachy, et al.
Published: (2017)

18[F] FDG-PET/CT is a useful molecular marker in evaluating thymoma aggressiveness.
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2011)

Significance of subcentimetre 18F-FDG PET/CT pulmonary abnormality in patients with known extrapulmonary malignancy.
by: Ahmad Saad , Fathinul Fikri, et al.
Published: (2010)

18F-FDG PET/CT as a potential predictor of survival in patient with oesophageal cancer: a preliminary result
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2015)

Agreement between various measurements of standardised uptake value normalised by lean body mass in detecting background 18F-FDG activity in PET/CT oncologic imaging
by: Mohad Azmi, Nur Hafizah
Published: (2018)

Immunohistophenotyping and 18F-FDG PET-CT in characterizing malignant breast tumors: preliminary results
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2020)

Potential use of integrated multimodality imaging 18F-FDG PET-CT in the evaluation of inflammatory bowel disease: a brief report
by: Nordin, Abdul Jalil, et al.
Published: (2022)

Analysis and establishment of adult diagnostic reference level for whole-body 18F-FDG PET/CT imaging: A single institutional study
by: Ahmad Faez, Mohamed Ridhwan, et al.
Published: (2023)

Whole body imaging using 18-Fluorine Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) with or without contrast enhanced computed tomography (CT) in dignosing arteritis
by: Nordin, Abdul Jalil, et al.
Published: (2009)

18[F]FDG-PET/CT is a useful molecular marker in evaluating tumour aggressiveness: a revised understanding of an in-vivo FDG-PET imaging that alludes the alteration of cancer biology
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2013)

Impact of prolonged reduced-pressure condition prior to precursor labeling on the labeling efficiency of F-18 fluorocholine synthesis
by: Hassan, Hishar, et al.
Published: (2018)

Assessment of lifetime attributable risk (LAR) of cancer incidence from whole-body 18F-FDG PET/CT examinations using established polynomial fittings
by: Murat, H., et al.
Published: (2025)

Clinical applications of the standard uptake values of the contrasted 18[F]FDG-PET/CT in nasopharyngeal carcinoma patients.
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2011)

An intense 18F-FDG pulmonary microfocus on PET without detectable abnormality on CT: a manifestation of an iatrogenic FDG pulmonary embolus
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2010)

Synthesis of fluorine-18-labelled choline (18F-fluorocholine): towards an early and accurate management of prostate cancer in Malaysia
by: Hassan, Muhammad Hishar, et al.
Published: (2016)

Correlation between 18F-FDG dosage and SNR on various BMI patient groups tested in NEMA IEC PET phantom
by: Waeleh, Nazreen, et al.
Published: (2021)

Localization and prediction of malignant potential in recurrent pheochromocytoma/paraganglioma (PCC/PGL) using 18F-FDG PET/CT
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2014)

Disseminated tuberculosis infection : a super 18F-FDG PET/CT appearance.
by: Nordin, Abdul Jalil, et al.
Published: (2009)

Reliability of standardized uptake value normalized to lean body mass using the liver as a reference organ, in contrast-enhanced 18F-FDG PET/CT imaging
by: Mohad Azmi, Nur Hafizah, et al.
Published: (2018)

Optimal 18F-fluorination conditions for the high radiochemical yield of [18F]AlF-NOTA-NHS complexes
by: Hassan, Hishar, et al.
Published: (2021)

Assessment of typical values for establishing institutional DRL of adult whole-body fluorine-18 fluorodeoxyglucose (FDG) PET/CT scans in Malaysia Cancer Centre
by: Murat, H., et al.
Published: (2025)

Brown fat uptake of 18F-FDG on dual time point PET/CT imaging.
by: Abdul Razak , Hairil Rashmizal, et al.
Published: (2010)

Inconsistency of lesion quantitative assessment in 2D SUV and 3D SUV quantification techniques for [18F]-FDG PET/CT: a phantom study
by: Hanafi, Muhammad Hafiz, et al.
Published: (2021)

Mapping 18F-fluorodeoxyglucose metabolism using PET/CT for the assessment of treatment response in non-small cell lung cancer patients undergoing epidermal growth factor receptor inhibitor treatment: a single-centre experience
by: Suppiah, Subapriya, et al.
Published: (2017)

The utility of [18]F-fluorocholine positron emission computed tomography and [18]F-fluorodeoxyglucose positron emission tomography–computed tomography in evaluating breast cancer phenotypes: a pilot study
by: Zakaria, Mohd Hazeman, et al.
Published: (2024)

PET/CT analysis of 21 patients with breast cancer: physiological distribution of ¹⁸F-choline and diagnostic pitfalls
by: Ahmad Saad, Fathinul Fikri, et al.
Published: (2018)

Novelty of 18F–fluorocholine computed-tomography (18-FCHPETCT) in prediciting quality of life in malignant breast cancer patients
by: Zakaria, mohd hazeman, et al.
Published: (2024)

Development of convenient quality control analysis method and improvement on the radiochemical yield using F-18-Labelled choline
by: Hassan, Muhammad Hishar
Published: (2016)